BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19744947)

  • 1. Proteasome inhibition during myocardial infarction.
    Yu X; Kem DC
    Cardiovasc Res; 2010 Jan; 85(2):312-20. PubMed ID: 19744947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More Than Just Cleaning: Ubiquitin-Mediated Proteolysis in Fungal Pathogenesis.
    Cao C; Xue C
    Front Cell Infect Microbiol; 2021; 11():774613. PubMed ID: 34858882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of deubiquitinases in cardiac disease.
    Zhan X; Yang Y; Li Q; He F
    Expert Rev Mol Med; 2024 Mar; 26():e3. PubMed ID: 38525836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between ubiquitin ligases and ncRNAs drives cardiovascular disease progression.
    You JR; Wen ZJ; Tian JW; Lv XB; Li R; Li SP; Xin H; Li PF; Zhang YF; Zhang R
    Front Immunol; 2024; 15():1335519. PubMed ID: 38515760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease.
    Zhao Y; Lin M; Zhai F; Chen J; Jin X
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death in the pathogenesis of heart disease: mechanisms and significance.
    Whelan RS; Kaplinskiy V; Kitsis RN
    Annu Rev Physiol; 2010; 72():19-44. PubMed ID: 20148665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting WWP1 ameliorates cardiac ischemic injury by suppressing KLF15-ubiquitination mediated myocardial inflammation.
    Lu X; Yang B; Qi R; Xie Q; Li T; Yang J; Tong T; Niu K; Li M; Pan W; Zhang Y; Shi D; Li S; Dai C; Shen C; Wang X; Wang Y; Song J
    Theranostics; 2023; 13(1):417-437. PubMed ID: 36593958
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost.
    Efentakis P; Andreadou I; Iliodromitis KE; Triposkiadis F; Ferdinandy P; Schulz R; Iliodromitis EK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria as a therapeutic target for cardiac ischemia‑reperfusion injury (Review).
    Marin W; Marin D; Ao X; Liu Y
    Int J Mol Med; 2021 Feb; 47(2):485-499. PubMed ID: 33416090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAT10 protects against ischemia-induced ventricular arrhythmia by decreasing Nedd4-2/Nav1.5 complex formation.
    Liu X; Ge J; Chen C; Shen Y; Xie J; Zhu X; Liu M; Hu J; Chen L; Guo L; Zhou Q; Yan X; Qiu Y; Wan R; Marian AJ; Hong K
    Cell Death Dis; 2021 Jan; 12(1):25. PubMed ID: 33414395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteostasis Regulation in the Endoplasmic Reticulum: An Emerging Theme in the Molecular Pathology and Therapeutic Management of Familial Hypercholesterolemia.
    Oommen D; Kizhakkedath P; Jawabri AA; Varghese DS; Ali BR
    Front Genet; 2020; 11():570355. PubMed ID: 33173538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity.
    Turkieh A; Porouchani S; Beseme O; Chwastyniak M; Amouyel P; Lamblin N; Balligand JL; Bauters C; Pinet F
    Cell Death Dis; 2019 Aug; 10(8):608. PubMed ID: 31406108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury.
    Hu C; Tian Y; Xu H; Pan B; Terpstra EM; Wu P; Wang H; Li F; Liu J; Wang X
    J Clin Invest; 2018 Dec; 128(12):5294-5306. PubMed ID: 30204128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSC70 is a chaperone for wild-type and mutant cardiac myosin binding protein C.
    Glazier AA; Hafeez N; Mellacheruvu D; Basrur V; Nesvizhskii AI; Lee LM; Shao H; Tang V; Yob JM; Gestwicki JE; Helms AS; Day SM
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling.
    Liu Y; Baumgardt SL; Fang J; Shi Y; Qiao S; Bosnjak ZJ; Vásquez-Vivar J; Xia Z; Warltier DC; Kersten JR; Ge ZD
    Sci Rep; 2017 Jun; 7(1):3093. PubMed ID: 28596578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia/Reperfusion.
    Kalogeris T; Baines CP; Krenz M; Korthuis RJ
    Compr Physiol; 2016 Dec; 7(1):113-170. PubMed ID: 28135002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death.
    Sanchez G; Berrios D; Olmedo I; Pezoa J; Riquelme JA; Montecinos L; Pedrozo Z; Donoso P
    PLoS One; 2016; 11(8):e0161068. PubMed ID: 27529620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial inhibition of the ubiquitin-proteasome system ameliorates cardiac dysfunction following ischemia-reperfusion in the presence of high glucose.
    Adams B; Mapanga RF; Essop MF
    Cardiovasc Diabetol; 2015 Jul; 14():94. PubMed ID: 26216448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated microRNA and mRNA responses to acute human left ventricular ischemia.
    Saddic LA; Chang TW; Sigurdsson MI; Heydarpour M; Raby BA; Shernan SK; Aranki SF; Body SC; Muehlschlegel JD
    Physiol Genomics; 2015 Oct; 47(10):455-62. PubMed ID: 26175501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages.
    Rossi S; Di Filippo C; Gesualdo C; Potenza N; Russo A; Trotta MC; Zippo MV; Maisto R; Ferraraccio F; Simonelli F; D'Amico M
    Mediators Inflamm; 2015; 2015():149381. PubMed ID: 25684860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.